FORT WORTH: A new drug that could treat early-stage Alzheimer’s disease by reducing levels of the stress hormone in the brain is being trialled.
Patients with the most common form of dementia have been found to have elevated levels of the stress hormone cortisol in the brain, which may accelerate symptoms by promoting build-up of plaque.
Results of a trial of the safety of the drug in healthy people are expected within months, but there is enough confidence about its effectiveness to plan phase two trials…